Zenas BioPharma Inc.
ZBIO | NASDAQ
$25.93
-$2.53 (-8.89%)
At close: Nov 5, 2026, 4:00 PM ET
$24.56
-$1.37 (-5.28%)
After-hours:
Nov 5, 2026, 6:19 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1M | n/a | n/a | n/a | n/a | 10M | 5M | n/a | n/a | n/a | n/a | 50M | n/a | n/a | n/a |
Cost of Revenue | n/a | 6K | 55.72M | 5M | 43.03M | n/a | n/a | 33.53M | 33.81M | 22.65M | 20.42M | n/a | n/a | 15.35M | 15.97M |
Gross Profit | 1M | -6K | -55.72M | -5M | -43.03M | 10M | 5M | -33.53M | -33.81M | -22.65M | -20.42M | 50M | n/a | -15.35M | -15.97M |
Operating Income | -107.66M | -77.35M | -237.98M | -52.58M | -55.16M | -37.33M | -55.62M | -40.98M | -39.7M | -27.58M | -24.78M | 35.62M | -28.91M | -19.09M | -18.99M |
Interest Income | 6.6M | 3.02M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -111.34M | -80.99M | -240.34M | -51.5M | -52.2M | -33.78M | -52.18M | -38.61M | -37.98M | -27.8M | -24.29M | 35.61M | -29.05M | -19.1M | -18.99M |
Net Income | -111.46M | -80.99M | -240.44M | -51.5M | -52.22M | -33.57M | -52.6M | -38.61M | -37.98M | -27.8M | -24.59M | 35.61M | -29.05M | -19.1M | -18.99M |
Selling & General & Admin | 15.75M | 16.91M | 15.59M | 13.18M | 12.14M | 12.42M | 11.47M | 7.45M | 5.9M | 4.93M | 4.36M | 5.02M | 3.99M | 3.74M | 3.22M |
Research & Development | 62.91M | 60.44M | 222.39M | 34.4M | 43.03M | 34.92M | 49.16M | 33.53M | 33.81M | 22.65M | 20.42M | 9.35M | 14.92M | 15.35M | 15.77M |
Other Expenses | 30M | n/a | -55.72M | n/a | -43.03M | n/a | n/a | -33.53M | -33.81M | -22.65M | -20.42M | n/a | 10M | -15.35M | -15.97M |
Operating Expenses | 108.66M | 77.34M | 182.26M | 47.58M | 12.14M | 47.33M | 60.62M | 7.45M | 5.9M | 4.93M | 4.36M | 14.38M | 28.91M | 3.74M | 3.02M |
Interest Expense | 10.3M | 6.63M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | -1.49M | n/a | 803K | n/a | n/a | 200K | 543K | n/a | 200K | n/a | n/a | n/a | 700K |
Cost & Expenses | 108.66M | 77.35M | 237.98M | 52.58M | 55.16M | 47.33M | 60.62M | 40.98M | 39.7M | 27.58M | 24.78M | 14.38M | 28.91M | 19.09M | 18.99M |
Income Tax Expense | 114K | n/a | 106K | n/a | 20K | -205K | 429K | n/a | n/a | n/a | 301K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 63.11M | 55.62M | 46.49M | 42.16M | 41.87M | 41.8M | 41.79M | 41.78M | 38.32M | 38.32M | 38.32M | 41.78M | 38.32M | 38.32M | 38.32M |
Shares Outstanding (Diluted) | 63.11M | 55.62M | 46.49M | 42.16M | 41.87M | 41.8M | 41.79M | 41.78M | 38.32M | 38.32M | 38.32M | 41.78M | 38.32M | 38.32M | 38.32M |
EPS (Basic) | -1.77 | -1.46 | -5.17 | -1.22 | -1.25 | -0.80 | -1.26 | -0.92 | -0.99 | -0.73 | -0.64 | 0.21 | -0.76 | -0.50 | -0.50 |
EPS (Diluted) | -1.77 | -1.46 | -5.17 | -1.22 | -1.25 | -0.80 | -1.26 | -0.92 | -0.99 | -0.73 | -0.64 | 0.21 | -0.76 | -0.50 | -0.50 |
EBITDA | -101.04M | -74.35M | -230.41M | -51.49M | -52.19M | -33.76M | -52.14M | -38.57M | -37.94M | -27.77M | -24.26M | 35.63M | -18.88M | -19.07M | -18.97M |
EBIT | -101.04M | -74.36M | -230.42M | -51.5M | -52.2M | -33.78M | -52.18M | -38.61M | -37.98M | -27.8M | -24.29M | 35.61M | -18.91M | -19.1M | -18.99M |
Depreciation & Amortization | 4K | 6K | 10K | 11K | 12K | 23K | 33K | 36K | 35K | 33K | 30K | 26K | 29K | 28K | 25K |
Add to Watchlist
Select watchlists to add or remove ZBIO